Dimethylfumarate induces apoptosis in human mast cells

Experimental Dermatology

Volumn 22, Issue 11, 2013, Pages 719-724

  Förster, Anja ^a   Preussner, Liane M ^a,b   Seeger, Jens M ^a   Rabenhorst, Anja ^a   Kashkar, Hamid ^a   Mrowietz, Ulrich ^c   Hartmann, Karin ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MILTENYI BIOTEC GMBH   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Apoptosis; Dimethylfumarate; Fumaric acid esters; Mast cells; Psoriasis

Indexed keywords

CALCIUM BIS(MONOMETHYLFUMARATE); CASPASE 6; CASPASE 9; DEXAMETHASONE; FUMARIC ACID; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID METHYL ESTER; PROTEIN BAK; PROTEIN BAX; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CORD BLOOD DERIVED MAST CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; MAST CELL; PROTEIN EXPRESSION;

APOPTOSIS; DIMETHYLFUMARATE; FUMARIC ACID ESTERS; MAST CELLS; PSORIASIS;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CALCIUM; CASPASE 6; CASPASE 9; CELL DEATH; CELL LINE; DERMATOLOGIC AGENTS; DEXAMETHASONE; ETOPOSIDE; FUMARATES; HUMANS; INTERLEUKIN-8; MALEATES; MAST CELLS; METHOTREXATE; PSORIASIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84886788913     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12247     Document Type: Article

References (50)

1. Shelburne C P, Abraham S N. Adv Exp Med Biol 2011: 716: 162-185.
2. Metz M, Siebenhaar F, Maurer M. Immunobiology 2008: 213: 251-260.
3. Walker M E, Hatfield J K, Brown M A. Biochim Biophys Acta 2012: 1822: 57-65.
4. Harvima I T, Naukkarinen A, Harvima R J et al. Arch Dermatol Res 1990: 282: 428-433.
5. Petersen L J, Hansen U, Kristensen J K et al. Acta Derm Venereol 1998: 78: 190-193.
6. Pestelli E, Caproni M, Giomi B et al. Int J Tissue React 2001: 23: 97-103.
7. Lin A M, Rubin C J, Khandpur R et al. J Immunol 2011: 187: 490-500.
8. Hueber A J, Asquith D L, Miller A M et al. J Immunol 2010: 184: 3336-3340.
9. Couturier N, Zappulla J P, Lauwers-Cances V et al. J Neuroimmunol 2008: 195: 176-185.
10. Sayed B A, Walker M E, Brown M A. J Immunol 2011: 186: 3294-3298.
11. Secor V H, Secor W E, Gutekunst C A et al. J Exp Med 2000: 191: 813-822.
12. Rostami-Yazdi M, Mrowietz U. Clin Dermatol 2008: 26: 522-526.
13. Fox R J, Miller D H, Phillips J T et al. N Engl J Med 2012: 367: 1087-1097.
14. Gold R, Kappos L, Arnold D L et al. N Engl J Med 2012: 367: 1098-1107.
15. Mrowietz U, Christophers E, Altmeyer P. Br J Dermatol 1998: 138: 456-460.
16. Schimrigk S, Brune N, Hellwig K et al. Eur J Neurol 2006: 13: 604-610.
17. Wallbrecht K, Drick N, Hund A C et al. Exp Dermatol 2011: 20: 980-985.
18. Loewe R, Holnthoner W, Gröger M et al. J Immunol 2002: 168: 4781-4787.
19. Stoof T J, Flier J, Sampat S et al. Br J Dermatol 2001: 144: 1114-1120.
20. Zhu K, Mrowietz U. J Invest Dermatol 2001: 116: 203-208.
21. Ghoreschi K, Brück J, Kellerer C et al. J Exp Med 2011: 208: 2291-2303.
22. Treumer F, Zhu K, Gläser R et al. J Invest Dermatol 2003: 121: 1383-1388.
23. Litjens N H, Burggraaf J, van Strijen E et al. Br J Clin Pharmacol 2004: 58: 429-432.
24. Rostami-Yazdi M, Clement B, Schmidt T J et al. J Invest Dermatol 2009: 129: 231-234.
25. Rostami-Yazdi M, Clement B, Mrowietz U. Arch Dermatol Res 2010: 302: 531-538.
26. Dibbert S, Clement B, Skak-Nielsen T et al. Arch Dermatol Res 2013: 305: 447-451.
27. Lee D H, Stangel M, Gold R et al. Expert Rev Neurother 2013: 13: 951-958.
28. Butterfield J H, Weiler D, Dewald G et al. Leuk Res 1988: 12: 345-355.
29. Hartmann K, Henz B M, Krüger-Krasagakes S et al. Blood 1997: 89: 2863-2870.
30. Kashkar H, Krönke M, Jürgensmeier J M. Cell Death Differ 2002: 9: 750-757.
31. Kashkar H, Haefs C, Shin H et al. J Exp Med 2003: 198: 341-347.
32. Biedermann T, Kneilling M, Mailhammer R et al. J Exp Med 2000: 192: 1441-1452.
33. Gearing A J, Fincham N J, Bird C R et al. Cytokine 1990: 2: 68-75.
34. Bienenstock J, MacQueen G, Sestini P et al. Am Rev Respir Dis 1991: 143: S55-S58.
35. Sharkey K A, Mawe G M. Curr Opin Pharmacol 2002: 2: 669-677.
36. De Schepper H U, De Man J G, Moreels T G et al. Aliment Pharmacol Ther 2008: 27: 621-637.
37. De Winter B Y, van den Wijngaard R M, de Jonge W J. Biochim Biophys Acta 2012: 1822: 66-73.
38. Fang Y F, Liu T, Cao J. Zhejiang Da Xue Xue Bao Yi Xue Ban 2007: 36: 255-260.
39. Lu Y Y, Xuan Z Q, Li X Z. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2008: 26: 276-279.
40. Bratton S B, Salvesen G S. J Cell Sci 2010: 123: 3209-3214.
41. Inoue S, Browne G, Melino G et al. Cell Death Differ 2009: 16: 1053-1061.
42. Cowling V, Downward J. Cell Death Differ 2002: 9: 1046-1056.
43. Warbrick E V, Thomas A L, Williams C M. Toxicology 1997: 116: 211-218.
44. Finotto S, Mekori Y A, Metcalfe D D. J Clin Invest 1997: 99: 1721-1728.
45. Berent-Maoz B, Piliponsky A M, Daigle I et al. J Immunol 2006: 176: 2272-2278.
46. Samorapoompichit P, Steiner M, Lucas T et al. Leuk Lymphoma 2003: 44: 509-515.
47. Williams B A, Makrigiannis A P, Blay J et al. Int J Cancer 1997: 73: 416-423.
48. Jost P J, Grabow S, Gray D et al. Nature 2009: 460: 1035-1039.
49. Kashkar H. Clin Cancer Res 2010: 16: 4496-4502.
50. Seidel P, Roth M. Mediators Inflamm 2013: 2013: 875403.